SP
Suraj Prakash Bhatnagar
About Suraj Prakash Bhatnagar
Data last updated:
Suraj Prakash Bhatnagar is a Director at Orchid Mediservices And Research Private Limited (since 2018). The company operates in Healthcare. Orchid Mediservices And Research Private Limited reported revenue of ₹6.14 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 May 2018 | 2010 | ₹6.14 Cr (FY 2024) | Active |
Board colleagues of Suraj Prakash Bhatnagar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chitrarekha Surajprakash Bhatnagar | 08139557 | Orchid Mediservices And Research Private Limited | Director |
| Manish Dineshkumar Gandhi | 07968660 | Orchid Mediservices And Research Private Limited | Director |
| Manish Suraj Bhatnagar | 02994337 | Orchid Mediservices And Research Private Limited | Director |
| Rupesh Shah | 10064863 | Orchid Mediservices And Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suraj Prakash Bhatnagar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suraj Prakash Bhatnagar
Suraj Prakash Bhatnagar currently holds 1 directorship: Orchid Mediservices And Research Private Limited (Director, since 28 May 2018, revenue ₹6.14 Cr (FY 2024)).
Suraj Prakash Bhatnagar was first appointed on 28 May 2018 as Director at Orchid Mediservices And Research Private Limited.
The current boards of Suraj Prakash Bhatnagar's companies include Chitrarekha Surajprakash Bhatnagar (Orchid Mediservices And Research Private Limited), Manish Dineshkumar Gandhi (Orchid Mediservices And Research Private Limited), Manish Suraj Bhatnagar (Orchid Mediservices And Research Private Limited), Rupesh Shah (Orchid Mediservices And Research Private Limited).